The U.S. Food and Drug Administration approved the first alkaline test to determine COVID-19.
On Thursday, The FDA says He allegedly issued an emergency use permit for the InspectIR COVID-19 breathalyzer, which detects coronavirus infections through respiratory samples. Test results can be obtained within three minutes.
So far, widely available COVID-19 tests have been performed in human nests using Q-drop cake and then sample testing, whose results take several minutes from a rapid test to in a few days for a PCR examination.
“Today’s authorization is another example of rapid change in COVID-19 diagnostic testing,” Jeff Schuren, director of the FDA’s Center for Devices and Radiological Health, said in a statement. He noted that this change could help the current pandemic and “better position the United States for the next health emergency.”
In a study of over 2,000 people, it was found that the test had a sensitivity of 91.2% (correctly identified samples positive to COVID) and a specificity of 99.3% (correctly identified negative samples). Clinical The tests began in 2020But the device has also been specifically tested for the omcron variant, the FDA said.
According to the FDA, healthcare professionals can use a carry-on-size test on patients in doctor’s offices, hospitals, and mobile testing areas.
However highly contagious omicron BA.2 sub-variant With the spread of the coronavirus in the United States, cases began to rise nationwide. The incident rate is still lower than during the main peak of winter. Vaccination remains the best form of hospitalization and protection from the virus from death.
Source: Huffpost
